NLS Pharmaceutics Warrant
NLSPW
NLSPW was delisted on the 30th of October, 2025.
7 hedge funds and large institutions have $750K invested in NLS Pharmaceutics Warrant in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
2% less capital invested
Capital invested by funds: $765K → $750K (-$15K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$129K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$29K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AC
1
Armistice Capital
New York
| $250K | – | – | – |
|
2
Hudson Bay Capital Management
Stamford,
Connecticut
| $165K | – | – | – |
|
|
ACM
3
Altium Capital Management
New York
| $146K | +$129K | +200,000 | New |
|
|
WVP
4
Worth Venture Partners
Fort Lee,
New Jersey
| $97K | – | – | – |
|
|
AC
5
Ayrton Capital
Westport,
Connecticut
| $85K | +$110K | +170,100 | New |
|
6
Bank Julius Baer & Co
Zurich,
Switzerland
| $6K | – | – | – |
|
7
UBS Group
Zurich,
Switzerland
| $1K | – | – | – |
|
|
WAM
8
Warberg Asset Management
Winnetka,
Illinois
| – | -$29K | -35,480 | Closed |
|
NLSPW Hedge Fund Activity: Q4 2021 in Review
7 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in NLS Pharmaceutics Warrant (NLSPW) for Q4 2021, worth a combined $750K — down 2% from $765K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NLSPW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $129K. The largest seller was Warberg Asset Management, exiting entirely with an estimated $29K sold.
- 7 institutional investors held NLS Pharmaceutics Warrant (NLSPW) as of Q4 2021, up from 6 in Q3 2021.
- Funds reported $750K of NLS Pharmaceutics Warrant stock for Q4 2021, down 2% quarter-over-quarter.
- 2 funds opened new NLS Pharmaceutics Warrant positions in Q4 2021 and 1 closed out, a net change of +1 holder.
- The largest NLS Pharmaceutics Warrant buyer in Q4 2021 was Altium Capital Management, an estimated $129K added.
- The largest NLS Pharmaceutics Warrant seller in Q4 2021 was Warberg Asset Management, an estimated $29K sold.
Based on aggregated 13F filings for Q4 2021.